2005
DOI: 10.1159/000088259
|View full text |Cite
|
Sign up to set email alerts
|

Beta-Ray Brachytherapy of Retinoblastoma: Feasibility of a New Small-Sized Ruthenium-106 Plaque

Abstract: A non-comparative case observation study estimated the feasibility of brachytherapy for retinoblastoma with a newly designed ruthenium-106 plaque (label: CXS) with an 8-mm diameter of the irradiation zone. Methods: The new CXS plaque was used between 2001 and 2003 for brachytherapy of 13 retinoblastomas. Indications were recurrences after preceding local treatment or endophytic retinoblastoma with an impending vitreous tumour cell seeding. The prescribed radiation dose at the apex was 88 Gy (NIST-calibrated do… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
23
0
10

Year Published

2007
2007
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(33 citation statements)
references
References 25 publications
0
23
0
10
Order By: Relevance
“…To our knowledge, this is not only the first report of documented ciliary body recurrence with supraciliary space effusion, but also the first successful attempt of conservative treatment of ciliary retinoblastoma. [7][8][9][10] The accumulation of fluid in the supraciliary compartment secondary to tumor growth may represent a novel intra-ocular dissemination pathway for retinoblastoma cells. We recommend …”
Section: Discussionmentioning
confidence: 99%
“…To our knowledge, this is not only the first report of documented ciliary body recurrence with supraciliary space effusion, but also the first successful attempt of conservative treatment of ciliary retinoblastoma. [7][8][9][10] The accumulation of fluid in the supraciliary compartment secondary to tumor growth may represent a novel intra-ocular dissemination pathway for retinoblastoma cells. We recommend …”
Section: Discussionmentioning
confidence: 99%
“…The indications for plaque brachytherapy include solitary tumors that are located anterior to the equator up to the ora serrata and recurrent or residual tumors after primary chemotherapy or failed EBRT. [394041] Radioisotopes such as iodine (I 125 ) and ruthenium (Ru 106 ) are the most commonly used isotopes. Iodine (I 125 ) seeds are inserted into a gold carrier to protect normal surrounding tissue from radiation.…”
Section: Globe-saving Treatmentsmentioning
confidence: 99%
“…Alle neuen Therapieansätze versuchen, die perkutane Bestrahlung zu vermeiden. Bei kleineren Tumoren der Gruppe A und B eignen sich lokale ablative Verfahren wie die thermische Laserkoagulation, Kryokoaguation und lokale Strahlentherapie vorzugsweise mit einem Beta-Applikator [5]. In der Behandlung fortgeschrittener Retinoblastome hat sich in …”
Section: Genetische Diagnostikunclassified